Global Pharmatech Company Executives
| GBLP Stock | USD 0.05 0.00 0.00% |
Global Pharmatech employs about 217 people. The company is managed by 2 executives with a total tenure of roughly 18 years, averaging almost 9.0 years of service per executive, having 108.5 employees per reported executive. Discussion of Global Pharmatech's management performance can provide insight into the enterprise performance.
| Lian MBA Insider Chief Chairperson |
| Zongsheng Zhang Executive Chief Officer |
Global |
Global Pharmatech Management Team Effectiveness
The company has return on total asset (ROA) of (0.1039) % which means that it has lost $0.1039 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2259) %, meaning that it created substantial loss on money invested by shareholders. Global Pharmatech's management efficiency ratios could be used to measure how well Global Pharmatech manages its routine affairs as well as how well it operates its assets and liabilities.Global Pharmatech Workforce Comparison
Global Pharmatech is one of the top stocks in number of employees category among its peers. The total workforce of Consumer Staples industry is currently estimated at about 865. Global Pharmatech totals roughly 217 in number of employees claiming about 25% of stocks in Consumer Staples industry.
The company has Profit Margin (PM) of (0.7) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.73) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.73. Global Pharmatech Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Global Pharmatech Price Series Summation is a cross summation of Global Pharmatech price series and its benchmark/peer.
Global Pharmatech Notable Stakeholders
A Global Pharmatech stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Global Pharmatech often face trade-offs trying to please all of them. Global Pharmatech's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Global Pharmatech's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Lian MBA | Chief Chairperson | Profile | |
| Zongsheng Zhang | Chief Officer | Profile |
About Global Pharmatech Management Performance
The success or failure of an entity such as Global Pharmatech often depends on how effective the management is. Global Pharmatech management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Global management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Global management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Global Pharmatech, Inc. engages in the research, production, and development of herbal medicine, bio-medicine, chemical medicine, traditional chinese medicine, and dietary supplements primarily in China. Global Pharmatech, Inc. was founded in 2001 and is based in Changchun, China. Global Pharmatech operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 217 people.
Global Pharmatech Workforce Analysis
Traditionally, organizations such as Global Pharmatech use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Global Pharmatech within its industry.Global Pharmatech Manpower Efficiency
Return on Global Pharmatech Manpower
| Revenue Per Employee | 13K | |
| Revenue Per Executive | 1.4M | |
| Net Loss Per Employee | 15.2K | |
| Net Loss Per Executive | 1.6M | |
| Working Capital Per Employee | 18.4K | |
| Working Capital Per Executive | 2M |
Additional Tools for Global Pink Sheet Analysis
When running Global Pharmatech's price analysis, check to measure Global Pharmatech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Global Pharmatech is operating at the current time. Most of Global Pharmatech's value examination focuses on studying past and present price action to predict the probability of Global Pharmatech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Global Pharmatech's price. Additionally, you may evaluate how the addition of Global Pharmatech to your portfolios can decrease your overall portfolio volatility.